Source: The Chronicle Herald
A Halifax vaccine research centre will conduct Canada’s first human clinical trials of a potential COVID-19 vaccine.
The Canadian Center for Vaccinology will work with the Chinese pharmaceutical company CanSino Biologics and Canada’s National Research Council. The vaccinology centre operates as a collaboration among Dalhousie University, the IWK Health Centre and the Nova Scotia Health Authority.
Referred to as Ad5-nCoV, the vaccine candidate received Chinese regulatory approval earlier this year, allowing CanSino Biologics to move ahead with human clinical trials in China.
It is one of only a handful of vaccine candidates in the world against COVID-19 so far approved for initial safety testing in humans, the National Research Council said in a news release.